These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31659655)

  • 1. Primary Care Providers' Acceptance of Pharmacists' Recommendations to Support Optimal Medication Management for Patients with Diabetic Kidney Disease.
    Zullig LL; Jazowski SA; Davenport CA; Diamantidis CJ; Oakes MM; Patel S; Moaddeb J; Bosworth HB
    J Gen Intern Med; 2020 Jan; 35(1):63-69. PubMed ID: 31659655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) study: Protocol and baseline characteristics of a randomized controlled trial.
    Diamantidis CJ; Bosworth HB; Oakes MM; Davenport CA; Pendergast JF; Patel S; Moaddeb J; Barnhart HX; Merrill PD; Baloch K; Crowley MJ; Patel UD
    Contemp Clin Trials; 2018 Jun; 69():28-39. PubMed ID: 29649631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capsule Commentary on Zullig et al., Primary Care Providers' Acceptance of Pharmacists' Recommendations to Support Optimal Medication Management for Patients with Diabetic Kidney Disease.
    Kuo T
    J Gen Intern Med; 2020 Jan; 35(1):406. PubMed ID: 31677100
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of medication-related problems and health care provider acceptance of pharmacist recommendations in the DiabetesCARE program.
    DeName B; Divine H; Nicholas A; Steinke DT; Johnson CL
    J Am Pharm Assoc (2003); 2008; 48(6):731-6. PubMed ID: 19019801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Pharmacist-Written Recommendations to Providers in a Medicare Advantage Plan: Factors Associated with Provider Acceptance.
    Mann A; Esse T; Abughosh SM; Serna O
    J Manag Care Spec Pharm; 2016 Jan; 22(1):49-55. PubMed ID: 27015051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a pharmacist-led pilot service based on the anticholinergic risk scale.
    Hanus RJ; Lisowe KS; Eickhoff JC; Kieser MA; Statz-Paynter JL; Zorek JA
    J Am Pharm Assoc (2003); 2016; 56(5):555-61. PubMed ID: 27053078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deprescribing in the context of multiple providers: understanding patient preferences.
    Linsky A; Meterko M; Bokhour BG; Stolzmann K; Simon SR
    Am J Manag Care; 2019 Apr; 25(4):192-198. PubMed ID: 30986016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing the acceptance of referrals for clinical pharmacist managed disease states in primary care.
    Bhat S; Kroehl M; Yi WM; Jaeger J; Thompson AM; Lam HM; Loeb D; Trinkley KE
    J Am Pharm Assoc (2003); 2019; 59(3):336-342. PubMed ID: 30948239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
    Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R
    BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Provider perceptions of pharmacists providing mental health medication support in patient-centered medical homes.
    Coe AB; Bostwick JR; Choe HM; Thompson AN
    J Am Pharm Assoc (2003); 2019; 59(4):555-559. PubMed ID: 31010786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of community pharmacists' recommendations in the North Carolina Medicaid medication therapy management program.
    Michaels NM; Jenkins GF; Pruss DL; Heidrick JE; Ferreri SP
    J Am Pharm Assoc (2003); 2010; 50(3):347-53. PubMed ID: 20452907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary care clinician perspectives on automated nephrology e-consults for diabetic kidney disease: a pre-implementation qualitative study.
    Chu CD; Dohan D; Estrella MM; Shlipak MG; Tuot DS
    BMC Prim Care; 2024 Jun; 25(1):197. PubMed ID: 38834994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective evaluation of medication appropriateness and clinical pharmacist drug therapy recommendations for home-based primary care veterans.
    Davis RG; Hepfinger CA; Sauer KA; Wilhardt MS
    Am J Geriatr Pharmacother; 2007 Mar; 5(1):40-7. PubMed ID: 17608246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Management with a Diabetes Team Using Home Telemedicine: Acceptance of Treatment Recommendations by Primary Care Providers in IDEATel.
    Izquierdo RE; Wang D; Huang D; Palmas W; Weinstock RS
    Telemed J E Health; 2015 Dec; 21(12):980-6. PubMed ID: 26114996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescriber acceptance rate of pharmacists' recommendations.
    Doellner JF; Dettloff RW; DeVuyst-Miller S; Wenstrom KL
    J Am Pharm Assoc (2003); 2017; 57(3S):S197-S202. PubMed ID: 28408169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Description of pharmacist interventions during physician-pharmacist co-management of hypertension.
    Von Muenster SJ; Carter BL; Weber CA; Ernst ME; Milchak JL; Steffensmeier JJ; Xu Y
    Pharm World Sci; 2008 Jan; 30(1):128-35. PubMed ID: 17710561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating provider acceptance of pharmacist interventions in the Discharge Companion Program and its association with readmission reduction.
    Jamjoom O; Marupuru S; Taylor AM; Warholak T; Scovis N; Bingham JM
    J Am Pharm Assoc (2003); 2020; 60(4):e47-e51. PubMed ID: 32037307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Care Providers Believe That Comprehensive Medication Management Improves Their Work-Life.
    Funk KA; Pestka DL; Roth McClurg MT; Carroll JK; Sorensen TD
    J Am Board Fam Med; 2019; 32(4):462-473. PubMed ID: 31300566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist-provider collaborative visits after hospital discharge in a comprehensive acute kidney injury survivor model.
    Herges JR; May HP; Meade L; Anderson B; Tinaglia AG; Schreier DJ; Kashani KB; Kattah A; McCoy RG; Rule AD; Mara KC; Barreto EF;
    J Am Pharm Assoc (2003); 2023; 63(3):909-914. PubMed ID: 36702735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.